CEVA

CEVA, Inc. NASDAQ

Technology ·Semiconductors ·US · ceva-dsp.com

$32.53

Mkt Cap $906.3M

52w Low $17.02 96.1% of range 52w High $33.16

50d MA $21.24 200d MA $23.06

P/E (TTM) -73.4x

EV/EBITDA -925.6x

P/B 2.3x

Debt/Equity 0.1x

ROE -3.2%

P/FCF 1013.2x

RSI (14) —

ATR (14) —

Beta 1.53

50d MA $21.24

200d MA $23.06

Avg Volume 425.7K

About

CEVA, Inc. operates as a licensor of wireless connectivity and smart sensing technologies to semiconductor and original equipment manufacturer (OEM) companies worldwide. It designs and licenses various digital signal processors, AI processors, wireless platforms, and complementary software for sensor fusion, image enhancement, computer vision, voice input, and artificial intelligence (AI). The com…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 17, 2026	AMC	0.18	0.18	+0.0%	20.45	-2.2%	-1.8%	-3.8%	-4.8%	-8.3%	-1.6%	—
Nov 10, 2025	AMC	0.10	0.11	+10.0%	26.01	+3.8%	+0.3%	+4.9%	-4.0%	-5.5%	-9.3%	—
Aug 11, 2025	AMC	0.05	0.07	+40.0%	21.33	+0.8%	+10.6%	+14.3%	+13.0%	+9.3%	+11.2%	—
May 7, 2025	AMC	0.07	0.06	-14.3%	21.14	+0.0%	-4.3%	-5.0%	+1.8%	+4.9%	+4.7%	—
Feb 13, 2025	AMC	0.11	0.11	+0.0%	34.96	+2.8%	-0.8%	+2.3%	+2.8%	+4.6%	-1.3%	—
Nov 7, 2024	AMC	0.09	0.14	+55.6%	29.34	+2.2%	-3.6%	-4.1%	-4.6%	-5.6%	-6.7%	—
Aug 7, 2024	AMC	0.02	0.17	+628.8%	19.44	+4.7%	+5.2%	+5.1%	+3.8%	+11.7%	+15.0%	—
May 9, 2024	AMC	-0.01	-0.05	-292.5%	20.25	-1.4%	-3.2%	-3.9%	-0.8%	+0.7%	-0.4%	—
Feb 14, 2024	AMC	0.06	0.10	+66.7%	24.51	+2.0%	-0.1%	-6.0%	-7.3%	-8.0%	-8.9%	—
Nov 8, 2023	AMC	0.04	0.02	-44.4%	19.68	+1.8%	-4.8%	+1.1%	+1.5%	+11.7%	+13.0%	—
Aug 9, 2023	AMC	0.08	-0.02	-125.0%	22.06	-3.1%	-0.4%	-2.0%	-6.0%	-8.1%	-10.2%	—
May 10, 2023	AMC	0.12	-0.16	-233.3%	21.31	-1.5%	-1.0%	-1.5%	+1.4%	+0.0%	+0.6%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 12	Rosenblatt	Maintains	Buy → Buy	—	$19.87	$19.50	-1.9%	-7.4%	-8.2%	-6.1%	-6.9%	-6.8%
Feb 18	Oppenheimer	Maintains	Outperform → Outperform	—	$20.45	$20.00	-2.2%	-1.8%	-3.8%	-4.8%	-8.3%	-1.6%
Feb 18	Rosenblatt	Maintains	Buy → Buy	—	$20.45	$20.00	-2.2%	-1.8%	-3.8%	-4.8%	-8.3%	-1.6%
Nov 12	Barclays	Maintains	Overweight → Overweight	—	$26.08	$26.80	+2.8%	+4.6%	-4.3%	-5.8%	-9.6%	-22.7%
Nov 11	Rosenblatt	Maintains	Buy → Buy	—	$26.01	$26.99	+3.8%	+0.3%	+4.9%	-4.0%	-5.5%	-9.3%
Aug 14	Rosenblatt	Maintains	Buy → Buy	—	$24.37	$23.78	-2.4%	-1.1%	-4.3%	-2.7%	-7.0%	-8.9%
May 9	Oppenheimer	Maintains	Outperform → Outperform	—	$20.24	$20.51	+1.3%	-0.8%	+6.3%	+9.5%	+9.4%	+5.4%
May 8	Rosenblatt	Maintains	Buy → Buy	—	$21.14	$21.14	+0.0%	-4.3%	-5.0%	+1.8%	+4.9%	+4.7%
May 8	Barclays	Maintains	Overweight → Overweight	—	$21.14	$21.14	+0.0%	-4.3%	-5.0%	+1.8%	+4.9%	+4.7%
Apr 23	Rosenblatt	Maintains	Buy → Buy	—	$23.50	$24.45	+4.0%	+8.6%	+13.0%	+13.7%	+13.1%	+12.7%
Feb 14	Rosenblatt	Maintains	Buy → Buy	—	$34.96	$35.95	+2.8%	-0.8%	+2.3%	+2.8%	+4.6%	-1.3%
Feb 14	Barclays	Maintains	Overweight → Overweight	—	$34.96	$35.95	+2.8%	-0.8%	+2.3%	+2.8%	+4.6%	-1.3%
Feb 11	Rosenblatt	Maintains	Buy → Buy	—	$32.73	$32.13	-1.8%	-1.8%	-3.1%	+6.8%	+5.9%	+9.3%
Dec 23	Northland Capital Markets	Maintains	Outperform → Outperform	—	$31.11	$31.20	+0.3%	+2.3%	+3.7%	+6.7%	+4.1%	+3.0%
Nov 8	Roth MKM	Maintains	Buy → Buy	—	$29.34	$30.00	+2.2%	-3.6%	-4.1%	-4.6%	-5.6%	-6.7%
Nov 8	Rosenblatt	Maintains	Buy → Buy	—	$29.34	$30.00	+2.2%	-3.6%	-4.1%	-4.6%	-5.6%	-6.7%
Oct 31	Rosenblatt	Maintains	Buy → Buy	—	$24.42	$24.37	-0.2%	-4.4%	-3.0%	-3.2%	-2.1%	+3.1%
Aug 8	Roth MKM	Upgrade	Neutral → Buy	—	$19.44	$20.36	+4.7%	+5.2%	+5.1%	+3.8%	+11.7%	+15.0%
Aug 8	Oppenheimer	Maintains	Outperform → Outperform	—	$19.44	$20.36	+4.7%	+5.2%	+5.1%	+3.8%	+11.7%	+15.0%
May 10	Roth MKM	Maintains	Neutral → Neutral	—	$20.25	$19.96	-1.4%	-3.2%	-3.9%	-0.8%	+0.7%	-0.4%
Feb 13	Rosenblatt	Maintains	Buy → Buy	—	$21.93	$20.84	-5.0%	-7.9%	+11.8%	+11.7%	+5.1%	+3.6%
Dec 7	Rosenblatt	Maintains	Buy → Buy	—	$21.79	$22.11	+1.5%	-1.2%	-0.7%	+4.4%	+1.7%	+3.3%
Aug 11	Barclays	Maintains	Overweight → Overweight	—	$21.97	$21.64	-1.5%	-1.6%	-5.6%	-7.7%	-9.8%	-7.2%
Aug 10	Rosenblatt	Maintains	Buy → Buy	—	$22.06	$21.37	-3.1%	-0.4%	-2.0%	-6.0%	-8.1%	-10.2%
Aug 10	Roth MKM	Downgrade	Buy → Neutral	—	$22.06	$21.37	-3.1%	-0.4%	-2.0%	-6.0%	-8.1%	-10.2%
Aug 10	Barclays	Maintains	Overweight → Overweight	—	$22.06	$21.37	-3.1%	-0.4%	-2.0%	-6.0%	-8.1%	-10.2%
Aug 10	Northland Capital Markets	Maintains	Outperform → Outperform	—	$22.06	$21.37	-3.1%	-0.4%	-2.0%	-6.0%	-8.1%	-10.2%
May 11	TD Cowen	Maintains	Outperform → Outperform	—	$21.31	$21.00	-1.5%	-1.0%	-1.5%	+1.4%	+0.0%	+0.6%
May 11	Roth MKM	Maintains	Buy → Buy	—	$21.31	$21.00	-1.5%	-1.0%	-1.5%	+1.4%	+0.0%	+0.6%
May 11	Barclays	Maintains	Overweight → Overweight	—	$21.31	$21.00	-1.5%	-1.0%	-1.5%	+1.4%	+0.0%	+0.6%
May 11	Oppenheimer	Maintains	Outperform → Outperform	—	$21.31	$21.00	-1.5%	-1.0%	-1.5%	+1.4%	+0.0%	+0.6%
Feb 17	Barclays	Maintains	Overweight → Overweight	—	$32.65	$32.97	+1.0%	+1.1%	-2.1%	-2.7%	-1.3%	-3.0%
Feb 16	Cowen & Co.	Maintains	Outperform → Outperform	—	$34.66	$34.98	+0.9%	-5.8%	-4.8%	-7.7%	-8.3%	-7.1%
Nov 11	Barclays	Maintains	Overweight → Overweight	—	$28.19	$28.00	-0.7%	+0.4%	-0.6%	+3.0%	+0.6%	+1.0%
Nov 10	Rosenblatt	Maintains	Buy → Buy	—	$26.05	$27.38	+5.1%	+8.2%	+8.7%	+7.6%	+11.4%	+8.9%
Feb 16	Rosenblatt	Upgrade	Neutral → Buy	—	$40.00	$41.24	+3.1%	+4.8%	+0.7%	+0.3%	-2.4%	-4.7%
May 11	Northland Capital Markets	Upgrade	Market Perform → Outperform	—	$42.40	$42.25	-0.4%	+7.9%	+0.2%	-3.2%	+0.8%	+0.8%
May 11	Barclays	Upgrade	Equal Weight → Overweight	—	$42.40	$42.25	-0.4%	+7.9%	+0.2%	-3.2%	+0.8%	+0.8%
Feb 17	Roth Capital	Maintains	Buy → Buy	—	$74.11	$73.00	-1.5%	-3.8%	-9.5%	-5.2%	-9.4%	-10.6%
Sep 21	Northland Capital Markets	Upgrade	Market Perform → Outperform	—	$36.86	$37.00	+0.4%	+0.9%	+2.6%	-0.6%	+1.1%	+2.2%
Mar 30	Northland Capital Markets	Upgrade	Market Perform → Outperform	—	$21.05	$21.73	+3.2%	+12.8%	+18.4%	+16.8%	+23.7%	+22.2%
Mar 30	Northland Securities	Upgrade	Market Perform → Outperform	—	$21.05	$21.73	+3.2%	+12.8%	+18.4%	+16.8%	+23.7%	+22.2%
Aug 9	Canaccord Genuity	Maintains	Buy → Buy	—	$31.40	$32.15	+2.4%	-3.2%	-0.9%	+2.1%	+0.3%	-1.6%
Apr 17	Exane BNP Paribas	Downgrade	Outperform → Neutral	—	$27.78	$25.07	-9.8%	-13.6%	-16.1%	-14.4%	-13.6%	-11.4%
Feb 14	Northland Securities	Downgrade	Outperform → Market Perform	—	$28.59	$27.41	-4.1%	-3.3%	+1.2%	-0.1%	+0.1%	+0.4%
Feb 14	Northland Capital Markets	Downgrade	Outperform → Market Perform	—	$28.59	$27.41	-4.1%	-3.3%	+1.2%	-0.1%	+0.1%	+0.4%
Oct 16	Canaccord Genuity	Maintains	Buy → Buy	—	$24.96	$25.85	+3.6%	+9.6%	+8.2%	+4.9%	+3.6%	+2.8%
Aug 8	Barclays	Maintains	Overweight → Overweight	—	$27.60	$27.40	-0.7%	+3.4%	+7.6%	+7.2%	+6.2%	+7.2%
May 10	Canaccord Genuity	Maintains	Buy → Buy	—	$30.05	$29.70	-1.2%	+0.7%	+2.5%	+5.2%	+7.2%	+9.0%
Feb 7	Barclays	Maintains	Overweight → Overweight	—	$39.75	$39.20	-1.4%	-9.3%	-11.9%	-8.4%	-9.9%	-10.3%

Recent Filings

8-K · 5.02 !!! Very High

CEVA Inc. -- 8-K 5.02: Executive Change

CEVA Inc. loses executive Sven-Christer Nilsson as he declines re-election, potentially signaling leadership transition and uncertainty for investors monitoring the semiconductor IP company's strategic direction.

Apr 20

8-K

CEVA Inc. -- 8-K Filing

CEVA Inc. reported fourth quarter and full year 2025 financial results, with CFO Yaniv Arieli disclosing earnings that investors should evaluate for revenue trends and profitability metrics.

Feb 17

Data updated apr 25, 2026 12:50am · Source: massive.com